Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 241 to 252 of 252 entries
Sorted by: Best Match Show Resources per page
[No title available]

Annales de cardiologie et d'angeiologie

Amara W, Reynaud N, Auquier N, Jourda F, Milhem A, Socié P, Pfeffer A, Mlayeh D, Bader H, Taieb J.
PMID: 34635329
Ann Cardiol Angeiol (Paris). 2021 Nov;70(5):351-354. doi: 10.1016/j.ancard.2021.09.001. Epub 2021 Oct 09.

No abstract available.

Cite
Amara W, Reynaud N, Auquier N, et al. Pratiques de télésurveillance des stimulateurs et défibrillateurs cardiaques en 2021 en France : résultats d'une enquête nationale. . Ann Cardiol Angeiol (Paris). 2021;70(5):351-354doi: 10.1016/j.ancard.2021.09.001.
Amara, W., Reynaud, N., Auquier, N., Jourda, F., Milhem, A., Socié, P., Pfeffer, A., Mlayeh, D., Bader, H., & Taieb, J. (2021). Pratiques de télésurveillance des stimulateurs et défibrillateurs cardiaques en 2021 en France : résultats d'une enquête nationale. . Annales de cardiologie et d'angeiologie, 70(5), 351-354. https://doi.org/10.1016/j.ancard.2021.09.001
Amara, Walid, et al. "Pratiques de télésurveillance des stimulateurs et défibrillateurs cardiaques en 2021 en France : résultats d'une enquête nationale." . Annales de cardiologie et d'angeiologie vol. 70,5 (2021): 351-354. doi: https://doi.org/10.1016/j.ancard.2021.09.001
Amara W, Reynaud N, Auquier N, Jourda F, Milhem A, Socié P, Pfeffer A, Mlayeh D, Bader H, Taieb J. Pratiques de télésurveillance des stimulateurs et défibrillateurs cardiaques en 2021 en France : résultats d'une enquête nationale. . Ann Cardiol Angeiol (Paris). 2021 Nov;70(5):351-354. doi: 10.1016/j.ancard.2021.09.001. Epub 2021 Oct 09. French. PMID: 34635329.
Copy Download .nbib Format: NLM
Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial.

Circulation. Heart failure

Desai AS, Vaduganathan M, Cleland JG, Claggett BL, Barkoudah E, Finn P, McCausland FR, Yilmaz MB, Lefkowitz M, Shi V, Pfeffer MA, McMurray JJV, Solomon SD.
PMID: 34807713
Circ Heart Fail. 2021 Nov 22;CIRCHEARTFAILURE121008597. doi: 10.1161/CIRCHEARTFAILURE.121.008597. Epub 2021 Nov 22.

BACKGROUND: Patients with heart failure (HF) and preserved left ventricular ejection fraction comprise a heterogeneous group including some with mildly reduced EF. We hypothesized that mode of death differs by EF in ambulatory patients with HF and preserved left...

Cite
Desai AS, Vaduganathan M, Cleland JG, et al. Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial. Circ Heart Fail. 2021;CIRCHEARTFAILURE121008597doi: 10.1161/CIRCHEARTFAILURE.121.008597.
Desai, A. S., Vaduganathan, M., Cleland, J. G., Claggett, B. L., Barkoudah, E., Finn, P., McCausland, F. R., Yilmaz, M. B., Lefkowitz, M., Shi, V., Pfeffer, M. A., McMurray, J. J. V., & Solomon, S. D. (2021). Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial. Circulation. Heart failure, CIRCHEARTFAILURE121008597. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008597
Desai, Akshay S, et al. "Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial." Circulation. Heart failure vol. (2021): CIRCHEARTFAILURE121008597. doi: https://doi.org/10.1161/CIRCHEARTFAILURE.121.008597
Desai AS, Vaduganathan M, Cleland JG, Claggett BL, Barkoudah E, Finn P, McCausland FR, Yilmaz MB, Lefkowitz M, Shi V, Pfeffer MA, McMurray JJV, Solomon SD. Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial. Circ Heart Fail. 2021 Nov 22;CIRCHEARTFAILURE121008597. doi: 10.1161/CIRCHEARTFAILURE.121.008597. Epub 2021 Nov 22. PMID: 34807713.
Copy Download .nbib Format: NLM
Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells.

Bioorganic & medicinal chemistry

He Y, Yang C, Wang Y, Sacher JR, Sims MM, Pfeffer LM, Miller DD.
PMID: 34863065
Bioorg Med Chem. 2022 Jan 01;53:116533. doi: 10.1016/j.bmc.2021.116533. Epub 2021 Nov 27.

Glioblastoma (GBM) is the most aggressive and treatment-refractory malignant adult brain cancer. After standard of care therapy, the overall median survival for GBM is only ∼6 months with a 5-year survival

Cite
He Y, Yang C, Wang Y, et al. Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells. Bioorg Med Chem. 2021;53:116533doi: 10.1016/j.bmc.2021.116533.
He, Y., Yang, C., Wang, Y., Sacher, J. R., Sims, M. M., Pfeffer, L. M., & Miller, D. D. (2022). Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells. Bioorganic & medicinal chemistry, 53116533. https://doi.org/10.1016/j.bmc.2021.116533
He, Yali, et al. "Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells." Bioorganic & medicinal chemistry vol. 53 (2022): 116533. doi: https://doi.org/10.1016/j.bmc.2021.116533
He Y, Yang C, Wang Y, Sacher JR, Sims MM, Pfeffer LM, Miller DD. Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells. Bioorg Med Chem. 2022 Jan 01;53:116533. doi: 10.1016/j.bmc.2021.116533. Epub 2021 Nov 27. PMID: 34863065.
Copy Download .nbib Format: NLM
Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF.

Clinical research in cardiology : official journal of the German Cardiac Society

Ueland T, Gullestad L, Kou L, Young JB, Pfeffer MA, van Veldhuisen DJ, Swedberg K, Mcmurray JJV, Desai AS, Anand IS, Aukrust P.
PMID: 34611778
Clin Res Cardiol. 2021 Oct 05; doi: 10.1007/s00392-021-01944-6. Epub 2021 Oct 05.

AIMS: We aimed to assess the value of GDF-15, a stress-responsive cytokine, in predicting clinical outcomes in patients with heart failure (HF) with reduced ejection fraction (HFrEF) and anemia METHODS AND RESULTS: Serum GDF-15 was assessed in 1582 HFrEF...

Cite
Ueland T, Gullestad L, Kou L, et al. Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF. Clin Res Cardiol. 2021;doi: 10.1007/s00392-021-01944-6.
Ueland, T., Gullestad, L., Kou, L., Young, J. B., Pfeffer, M. A., van Veldhuisen, D. J., Swedberg, K., Mcmurray, J. J. V., Desai, A. S., Anand, I. S., & Aukrust, P. (2021). Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF. Clinical research in cardiology : official journal of the German Cardiac Society, . https://doi.org/10.1007/s00392-021-01944-6
Ueland, Thor, et al. "Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF." Clinical research in cardiology : official journal of the German Cardiac Society vol. (2021). doi: https://doi.org/10.1007/s00392-021-01944-6
Ueland T, Gullestad L, Kou L, Young JB, Pfeffer MA, van Veldhuisen DJ, Swedberg K, Mcmurray JJV, Desai AS, Anand IS, Aukrust P. Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF. Clin Res Cardiol. 2021 Oct 05; doi: 10.1007/s00392-021-01944-6. Epub 2021 Oct 05. PMID: 34611778.
Copy Download .nbib Format: NLM
Influence of study discontinuation during the run-in period on the estimated efficacy of sacubitril/valsartan in the PARAGON-HF trial.

European journal of heart failure

Suzuki K, Claggett B, Minamisawa M, Packer M, Zile MR, Pfeffer MA, Chiang LM, Lefkowitz M, McMurray JJV, Solomon SD, Desai AS.
PMID: 34114720
Eur J Heart Fail. 2021 Jun 11; doi: 10.1002/ejhf.2262. Epub 2021 Jun 11.

AIMS: The 4822 patients randomized in the PARAGON-HF trial were a subset of 5746 initially eligible patients who entered sequential run-in periods. We identified patient factors associated with study discontinuation during the run-in period and estimated the implications of...

Cite
Suzuki K, Claggett B, Minamisawa M, et al. Influence of study discontinuation during the run-in period on the estimated efficacy of sacubitril/valsartan in the PARAGON-HF trial. Eur J Heart Fail. 2021;doi: 10.1002/ejhf.2262.
Suzuki, K., Claggett, B., Minamisawa, M., Packer, M., Zile, M. R., Pfeffer, M. A., Chiang, L. M., Lefkowitz, M., McMurray, J. J. V., Solomon, S. D., & Desai, A. S. (2021). Influence of study discontinuation during the run-in period on the estimated efficacy of sacubitril/valsartan in the PARAGON-HF trial. European journal of heart failure, . https://doi.org/10.1002/ejhf.2262
Suzuki, Kota, et al. "Influence of study discontinuation during the run-in period on the estimated efficacy of sacubitril/valsartan in the PARAGON-HF trial." European journal of heart failure vol. (2021). doi: https://doi.org/10.1002/ejhf.2262
Suzuki K, Claggett B, Minamisawa M, Packer M, Zile MR, Pfeffer MA, Chiang LM, Lefkowitz M, McMurray JJV, Solomon SD, Desai AS. Influence of study discontinuation during the run-in period on the estimated efficacy of sacubitril/valsartan in the PARAGON-HF trial. Eur J Heart Fail. 2021 Jun 11; doi: 10.1002/ejhf.2262. Epub 2021 Jun 11. PMID: 34114720.
Copy Download .nbib Format: NLM
[No title available]

Frontiers in veterinary science

Obiegala A, Pfeffer M, Kiefer D, Kiefer M, Król N, Silaghi C.
PMID: 33537358
Front Vet Sci. 2021 Jan 18;7:625641. doi: 10.3389/fvets.2020.625641. eCollection 2020.

Most

Cite
Obiegala A, Pfeffer M, Kiefer D, et al. . Front Vet Sci. 2021;7:625641doi: 10.3389/fvets.2020.625641.
Obiegala, A., Pfeffer, M., Kiefer, D., Kiefer, M., Król, N., & Silaghi, C. (2020). . Frontiers in veterinary science, 7625641. https://doi.org/10.3389/fvets.2020.625641
Obiegala, Anna, et al. "." Frontiers in veterinary science vol. 7 (2020): 625641. doi: https://doi.org/10.3389/fvets.2020.625641
Obiegala A, Pfeffer M, Kiefer D, Kiefer M, Król N, Silaghi C. . Front Vet Sci. 2021 Jan 18;7:625641. doi: 10.3389/fvets.2020.625641. eCollection 2020. PMID: 33537358; PMCID: PMC7848210.
Copy Download .nbib Format: NLM
Direct Observation of Amide Bond Formation in a Plasmonic Nanocavity Triggered by Single Nanoparticle Collisions.

Journal of the American Chemical Society

Kong N, Guo J, Chang S, Pan J, Wang J, Zhou J, Liu J, Zhou H, Pfeffer FM, Liu J, Barrow CJ, He J, Yang W.
PMID: 34164979
J Am Chem Soc. 2021 Jul 07;143(26):9781-9790. doi: 10.1021/jacs.1c02426. Epub 2021 Jun 24.

The real-time observation of chemical bond formation at the single-molecule level is one of the great challenges in the fields of organic and biomolecular chemistry. Valuable information can be gleaned that is not accessible using ensemble-average measurements. Although remarkably...

Cite
Kong N, Guo J, Chang S, et al. Direct Observation of Amide Bond Formation in a Plasmonic Nanocavity Triggered by Single Nanoparticle Collisions. J Am Chem Soc. 2021;143(26):9781-9790doi: 10.1021/jacs.1c02426.
Kong, N., Guo, J., Chang, S., Pan, J., Wang, J., Zhou, J., Liu, J., Zhou, H., Pfeffer, F. M., Liu, J., Barrow, C. J., He, J., & Yang, W. (2021). Direct Observation of Amide Bond Formation in a Plasmonic Nanocavity Triggered by Single Nanoparticle Collisions. Journal of the American Chemical Society, 143(26), 9781-9790. https://doi.org/10.1021/jacs.1c02426
Kong, Na, et al. "Direct Observation of Amide Bond Formation in a Plasmonic Nanocavity Triggered by Single Nanoparticle Collisions." Journal of the American Chemical Society vol. 143,26 (2021): 9781-9790. doi: https://doi.org/10.1021/jacs.1c02426
Kong N, Guo J, Chang S, Pan J, Wang J, Zhou J, Liu J, Zhou H, Pfeffer FM, Liu J, Barrow CJ, He J, Yang W. Direct Observation of Amide Bond Formation in a Plasmonic Nanocavity Triggered by Single Nanoparticle Collisions. J Am Chem Soc. 2021 Jul 07;143(26):9781-9790. doi: 10.1021/jacs.1c02426. Epub 2021 Jun 24. PMID: 34164979.
Copy Download .nbib Format: NLM
Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction.

European journal of heart failure

Jackson AM, Rørth R, Liu J, Kristensen SL, Anand IS, Claggett BL, Cleland JGF, Chopra VK, Desai AS, Ge J, Gong J, Lam CSP, Lefkowitz MP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rizkala AR, Rouleau JL, Seferović PM, Tromp J, Van Veldhuisen DJ, Yilmaz MB, Zannad F, Zile MR, Køber L, Petrie MC, Jhund PS, Solomon SD, McMurray JJV.
PMID: 34918855
Eur J Heart Fail. 2021 Dec 17; doi: 10.1002/ejhf.2403. Epub 2021 Dec 17.

AIM: There is an association between heart failure with preserved ejection fraction (HFpEF) and insulin resistance, but less is known about the diabetic continuum, and in particular about pre-diabetes, in HFpEF. We examined characteristics and outcomes of participants with...

Cite
Jackson AM, Rørth R, Liu J, et al. Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2021;doi: 10.1002/ejhf.2403.
Jackson, A. M., Rørth, R., Liu, J., Kristensen, S. L., Anand, I. S., Claggett, B. L., Cleland, J. G. F., Chopra, V. K., Desai, A. S., Ge, J., Gong, J., Lam, C. S. P., Lefkowitz, M. P., Maggioni, A. P., Martinez, F., Packer, M., Pfeffer, M. A., Pieske, B., Redfield, M. M., Rizkala, A. R., Rouleau, J. L., Seferović, P. M., Tromp, J., Van Veldhuisen, D. J., Yilmaz, M. B., Zannad, F., Zile, M. R., Køber, L., Petrie, M. C., Jhund, P. S., Solomon, S. D., McMurray, J. J. V. (2021). Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction. European journal of heart failure, . https://doi.org/10.1002/ejhf.2403
Jackson, Alice M, et al. "Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction." European journal of heart failure vol. (2021). doi: https://doi.org/10.1002/ejhf.2403
Jackson AM, Rørth R, Liu J, Kristensen SL, Anand IS, Claggett BL, Cleland JGF, Chopra VK, Desai AS, Ge J, Gong J, Lam CSP, Lefkowitz MP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rizkala AR, Rouleau JL, Seferović PM, Tromp J, Van Veldhuisen DJ, Yilmaz MB, Zannad F, Zile MR, Køber L, Petrie MC, Jhund PS, Solomon SD, McMurray JJV. Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2021 Dec 17; doi: 10.1002/ejhf.2403. Epub 2021 Dec 17. PMID: 34918855.
Copy Download .nbib Format: NLM
Three-dimensional deformation measured in an alaskan glacier .

Science (New York, N.Y.)

Harper JT, Humphrey NF, Pfeffer WT.
PMID: 9721096
Science. 1998 Aug 28;281(5381):1340-2. doi: 10.1126/science.281.5381.1340.

Measurements of movement along 28 boreholes reveal the three-dimensional flow field in a 6 million cubic meter reach of Worthington Glacier, a temperate valley glacier located in Alaska. Sliding at the bed accounted for 60 to 70 percent of...

Cite
Harper JT, Humphrey NF, Pfeffer WT. Three-dimensional deformation measured in an alaskan glacier . Science. 1998;281(5381):1340-2doi: 10.1126/science.281.5381.1340.
Harper, J. T., Humphrey, N. F., & Pfeffer, W. T. (1998). Three-dimensional deformation measured in an alaskan glacier . Science (New York, N.Y.), 281(5381), 1340-2. https://doi.org/10.1126/science.281.5381.1340
Harper, et al. "Three-dimensional deformation measured in an alaskan glacier ." Science (New York, N.Y.) vol. 281,5381 (1998): 1340-2. doi: https://doi.org/10.1126/science.281.5381.1340
Harper JT, Humphrey NF, Pfeffer WT. Three-dimensional deformation measured in an alaskan glacier . Science. 1998 Aug 28;281(5381):1340-2. doi: 10.1126/science.281.5381.1340. PMID: 9721096.
Copy Download .nbib Format: NLM
Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON-HF.

Journal of the American Heart Association

Mooney L, Hawkins NM, Jhund PS, Redfield MM, Vaduganathan M, Desai AS, Rouleau JL, Minamisawa M, Shah AM, Lefkowitz MP, Zile MR, Van Veldhuisen DJ, Pfeffer MA, Anand IS, Maggioni AP, Senni M, Claggett BL, Solomon SD, McMurray JJV.
PMID: 34796742
J Am Heart Assoc. 2021 Dec 07;10(23):e021494. doi: 10.1161/JAHA.121.021494. Epub 2021 Nov 19.

Background Little is known about the impact of chronic obstructive pulmonary disease (COPD) in patients with heart failure with preserved ejection fraction (HFpEF). Methods and Results We examined outcomes in patients with heart failure with preserved ejection fraction, according...

Cite
Mooney L, Hawkins NM, Jhund PS, et al. Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON-HF. J Am Heart Assoc. 2021;10(23):e021494doi: 10.1161/JAHA.121.021494.
Mooney, L., Hawkins, N. M., Jhund, P. S., Redfield, M. M., Vaduganathan, M., Desai, A. S., Rouleau, J. L., Minamisawa, M., Shah, A. M., Lefkowitz, M. P., Zile, M. R., Van Veldhuisen, D. J., Pfeffer, M. A., Anand, I. S., Maggioni, A. P., Senni, M., Claggett, B. L., Solomon, S. D., & McMurray, J. J. V. (2021). Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON-HF. Journal of the American Heart Association, 10(23), e021494. https://doi.org/10.1161/JAHA.121.021494
Mooney, Leanne, et al. "Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON-HF." Journal of the American Heart Association vol. 10,23 (2021): e021494. doi: https://doi.org/10.1161/JAHA.121.021494
Mooney L, Hawkins NM, Jhund PS, Redfield MM, Vaduganathan M, Desai AS, Rouleau JL, Minamisawa M, Shah AM, Lefkowitz MP, Zile MR, Van Veldhuisen DJ, Pfeffer MA, Anand IS, Maggioni AP, Senni M, Claggett BL, Solomon SD, McMurray JJV. Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON-HF. J Am Heart Assoc. 2021 Dec 07;10(23):e021494. doi: 10.1161/JAHA.121.021494. Epub 2021 Nov 19. PMID: 34796742.
Copy Download .nbib Format: NLM
Men, trans/masculine, and non-binary people negotiating conception: Normative resistance and inventive pragmatism.

International journal of transgender health

Riggs DW, Pfeffer CA, Pearce R, Hines S, White FR.
PMID: 34476419
Int J Transgend Health. 2021 Sep 01;22(1):6-17. doi: 10.1080/15532739.2020.1808554. eCollection 2021.

BACKGROUND: Growing numbers of men, trans/masculine, and non-binary people are undertaking pregnancies, yet relatively little is known about the experiences of this diverse population in regard to conception.AIMS: This study sought to examine men's, trans/masculine, and non-binary people's experiences...

Cite
Riggs DW, Pfeffer CA, Pearce R, et al. Men, trans/masculine, and non-binary people negotiating conception: Normative resistance and inventive pragmatism. Int J Transgend Health. 2021;22(1):6-17doi: 10.1080/15532739.2020.1808554.
Riggs, D. W., Pfeffer, C. A., Pearce, R., Hines, S., & White, F. R. (2021). Men, trans/masculine, and non-binary people negotiating conception: Normative resistance and inventive pragmatism. International journal of transgender health, 22(1), 6-17. https://doi.org/10.1080/15532739.2020.1808554
Riggs, Damien W, et al. "Men, trans/masculine, and non-binary people negotiating conception: Normative resistance and inventive pragmatism." International journal of transgender health vol. 22,1 (2021): 6-17. doi: https://doi.org/10.1080/15532739.2020.1808554
Riggs DW, Pfeffer CA, Pearce R, Hines S, White FR. Men, trans/masculine, and non-binary people negotiating conception: Normative resistance and inventive pragmatism. Int J Transgend Health. 2021 Sep 01;22(1):6-17. doi: 10.1080/15532739.2020.1808554. eCollection 2021. PMID: 34476419; PMCID: PMC8040675.
Copy Download .nbib Format: NLM
The Society of Astrologers (.

British journal for the history of science

Pfeffer M.
PMID: 33719982
Br J Hist Sci. 2021 Jun;54(2):133-153. doi: 10.1017/S0007087421000029.

Before the Royal Society there was the Society of Astrologers (c.1647-1684), a group of around forty practitioners who met in London to enjoy lavish feasts, listen to sermons and exchange instruments and manuscripts. This article, drawing on untapped archival...

Cite
Pfeffer M. The Society of Astrologers (. Br J Hist Sci. 2021;54(2):133-153doi: 10.1017/S0007087421000029.
Pfeffer, M. (2021). The Society of Astrologers (. British journal for the history of science, 54(2), 133-153. https://doi.org/10.1017/S0007087421000029
Pfeffer, Michelle. "The Society of Astrologers (." British journal for the history of science vol. 54,2 (2021): 133-153. doi: https://doi.org/10.1017/S0007087421000029
Pfeffer M. The Society of Astrologers (. Br J Hist Sci. 2021 Jun;54(2):133-153. doi: 10.1017/S0007087421000029. PMID: 33719982.
Copy Download .nbib Format: NLM
Showing 241 to 252 of 252 entries